IART Q1 2026 Earnings Strong EPS Beat Amid Revenue Uncertainty LCI Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain VTGN Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Advances FUBO Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher Editas Medicine Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline